Philip Nickson
Consejero General en MONTE ROSA THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Philip Nickson is currently working as the General Counsel at Monte Rosa Therapeutics, Inc. He previously worked as the Vice President-Intellectual Property at Momenta Pharmaceuticals, Inc. from 2012 to 2021.
Dr. Nickson holds a doctorate degree from The University of Manchester and a graduate degree from Suffolk University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/01/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Philip Nickson
| Empresas | Cargo | Inicio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consejero General | 01/03/2021 |
Antiguos cargos conocidos de Philip Nickson.
| Empresas | Cargo | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2021 |
Formación de Philip Nickson.
| Suffolk University | Graduate Degree |
| The University of Manchester | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Nickson
